SUZ12 and cancer: In addition, EZH2 loss significantly promoted the development of myelodysplastic syndrome induced by transcription factor Runx1 mutation, and loss of SUZ12 synergizes with neurofibromin 1 (NF1) mutations to amplify Ras signaling to drive cancer [210,265,266].